Regional News

Gates Foundation Goalkeepers Report Says Progress Still Possible Despite Setbacks to Global Goals

Bill Gates and Melinda French Gates call on leaders to keep commitments to world's poorest and invest in innovation, ingenuity to continue saving millions of lives SEATTLE, Sept. 13, 2022 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its sixth annual Goalkeepers Report, noti...

2022-09-13 12:01 2414

McCain Foods Acquires Scelta Products

The acquisition will fuel future growth in the global prepared appetizers market to meet customer and consumer demand TORONTO, Sept. 13, 2022 /PRNewswire/ -- McCain Foods has acquired Scelta Products, addingthe Netherlands-based producer of frozen foods to its growing family of delicious, prepar...

2022-09-13 12:01 2568

MAXHUB introduces intelligent UC P25 PTZ camera for complete conferencing clarity

MAXHUB's UC P25 PTZ camera brings unrivaled imaging technology to virtual team meetings and conferences worldwide. Confidently collaborate with this premium solution that produces vibrant image and video quality, regardless of room size. MA...

2022-09-13 11:30 3245

Manulife appoints HyounJoo Choe as Chief Customer Officer for Hong Kong and Macau to spearhead customer experience and centricity

HONG KONG, Sept. 13, 2022 /PRNewswire/ -- Manulife Hong Kong today announced the appointment of HyounJoo Choe as Chief Customer Officer,Hong Kong and Macau. As a member of the senior management team, Ms Choe will lead all customer experience and strategic marketing functions including marketing, ...

2022-09-13 10:24 3250

UnionTech Completes $30M Funding Round Led by CITIC Goldstone

SHANGHAI, Sept. 12, 2022 /PRNewswire/ -- UnionTech, a leader in the 3D printing industry, is pleased to announce that it has recently completed a new Pre-IPO funding round following the completion of the Series D funding round in November last year. This funding round was led by CITIC Goldstone,...

2022-09-13 10:17 2079

NEXCOM's New Cyber Security Appliance Boosts Data Transfer Efficiency

TAIPEI, Sept. 12, 2022 /PRNewswire/ -- NEXCOM, a leading supplier of network appliances, announces a new addition to its well-establishedcyber security

2022-09-13 10:00 3415

University Of Auckland Scholarships Support Students From South-East Asia

HO CHI MINH CITY, Vietnam, Sept. 13, 2022 /PRNewswire/ -- New Zealand's leading university, the University ofAuckland, has just announced an extensive range of new scholarships for students fromSouth-East Asia, providing students with up to NZD10,000 of financial support. With the borders now ful...

2022-09-13 10:00 2783

Xinhua Silk Road: Putian City in E. China's Fujian galvanizes itself into one of world-leading incense trading hubs

BEIJING, Sept. 13, 2022 /PRNewswire/ -- Home to over 600 enterprises in the incense industry, the Putian Arts and Crafts City has seen a total output value of over6 billion yuan (about 865.2 million U.S. dollars), making Putian City in eastChina's Fujian Province one of the largest global hubs fo...

2022-09-13 09:40 3894

GLOBAL TIMES ONLINE: Weichai Power in Weifang accelerates commoditization of hydrogen fuel cell logistics vehicles

WEIFANG, China, Sept. 13, 2022 /PRNewswire/ -- Weichai Power Co., Ltd., based in Weifang city, eastChina's Shandong Province, and China National Heavy Duty Truck Group Co., Ltd, recently received an order for 1,100 fuel cell electric trucks placed by three companies. The 1,100 trucks, both heavy...

2022-09-13 09:25 2562

LG's super-giant AI, EXAONE become a pioneer in the design field with Parsons School of Design

NEW YORK, Sept. 12, 2022 /PRNewswire/ -- LG is stepping up efforts to develop artificial  intelligence(AI) that support humans in learning and expanding their creativity in art and design practices by leveraging the joint academic research partnership with Parsons School of  Design, the No. 1 U.S...

2022-09-13 09:15 2924

Microtech to unveil implantable microsensor technology at 34th Transcatheter Cardiovascular Therapeutics (TCT) annual meeting

TEL AVIV, Israel, Sept. 13, 2022 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, Inc., a leader in global MedTech research and development, announced that its implantable microsensor platform will be presented at the34th Transcatheter Cardiovascular Therapeutics (TCT), the annua...

2022-09-13 09:11 2389

WATERFALL SECURITY ANNOUNCES CYBERSECURITY PARTNERSHIP WITH ALSTOM

Waterfall's industrial cybersecurity products are trusted by critical infrastructures worldwide PARIS, Sept. 13, 2022 /PRNewswire/ -- Waterfall Security Solutions , the Operational Technology (OT) security company, today announced a collaboration agreement to ...

2022-09-13 09:00 4244

CNOOC Limited Announces Kenli 6-1 Oilfield 10-1 North Block Development Project Commenced Production

HONG KONG, Sept. 13, 2022 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883, SSE: 600938) announced today that Kenli 6-1 Oilfield 10-1 North Block Development Project commenced production. The development project locates in the south of Bohai Sea, with average water depth of about 19 m...

2022-09-13 08:18 2511

CStone announces China's NMPA has accepted and granted priority review to the supplemental new drug application (sNDA) for sugemalimab in the treatment of patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL)

* This is the third supplemental new drug application (NDA) that CStone has submitted for sugemalimab after the prior two for stage III and IV non-small cell lung cancer. Sugemalimab has the potential to become the world's first immuno-oncology therapy to be approved for patients with relapsed ...

2022-09-13 08:02 5102

Transcenta Releases Encouraging Interim Safety and Efficacy Data of the TST001 (Osemitamab) and Chemotherapy Combination Expansion Cohort for First Line Claudin18.2 Positive Gastric Cancer at ESMO Congress 2022

* In first line treatment of advanced or metastatic G/GEJ cancer, early interim data of the first 15 patients with measurable disease receiving the combination of TST001 (Osemitamab) with CAPOX demonstrated a partial response rate of 73.3% and a disease control rate of 100% per RECIST1.1. * B...

2022-09-13 08:00 3420

Ground-breaking report warns chemicals industry must dramatically transform operations to avoid 4⁰C of global warming

* Ground-breaking study sets out credible pathways for the industry to become an enabler of a sustainable global economy, double in size and create 29 million new jobs * The industry can reinvent itself as a climate solution – becoming carbon negative by early 2040s and acting as a carbon sin...

2022-09-13 07:01 3357

Kohler Co. Elects Current President and Chief Executive Officer David Kohler as Chair and Chief Executive Officer

KOHLER, Wis., Sept. 13, 2022 /PRNewswire/ -- The Kohler Co. Board of Directors has elected President and Chief Executive OfficerDavid Kohler to the additional role of Chair of the Board, following the passing of Executive ChairmanHerbert V. Kohler, Jr. on Sept. 3 at age 83. The Board of Directors...

2022-09-13 06:45 2456

KAFA Partners with Minerva Project to Launch New Higher Educational Institution

SAN FRANCISCO and SEOUL, Korea, Sept. 13, 2022 /PRNewswire/ --The Korea-ASEAN Friendship Association (KAFA) has entered into a partnership withMinerva Project  to build a new educational institution, based on the Minerva model. This is the only comprehensive implementation of the Minerva system in...

2022-09-13 06:40 5097

Financial Times: Leipzig Has One of the 20 Best Business Schools in the World

LEIPZIG, Germany, Sept. 13, 2022 /PRNewswire/ -- HHL Leipzig Graduate School of Management (HHL) has achieved 19th place worldwide and third place inGermany in the annual ranking of theFinancial Times. This makes HHL's Master in Management program one of the best in the world. According to the ra...

2022-09-13 06:31 2083

Starpharma presents compelling data in Prostate Cancer at ESMO

MELBOURNE, Australia, Sept. 13, 2022 /PRNewswire/ -- Cabazitaxel (Jevtana, Sanofi) is a market leading chemotherapy for the treatment of advanced prostate cancer (mCRPC).  Developed by Australian biotech company Starpharma, DEP® cabazitaxel is a patented, highly water soluble dendrimer nanopartic...

2022-09-13 06:28 2230